IFNA1 and neoplasm: The low- and high-risk patients in the TCGA dataset (all adjusted p’s < 0.05; Fig. 1C) significantly differed in the content of the antigen presentation process, including scores for dendritic cells (DC), activated DCs, B cells, mast cells, neutrophils, immature DCs, plasmacytoid DCs, T helper cells, tumor-infiltrating lymphocytes, human leukocyte antigen, major histocompatibility complex class I molecules, type II interferon (IFN) responses, and type I IFN responses.